1. Kahn JG, Washington AE, Showstack JA, Berlin M, Phillips K. Updated Estimates of the Impact and Cost of HIV Prevention in Injection Drug Users. Final report prepared for the Centers for Disease Control and Prevention. San Francisco Institute for Health Policy Studies, University of California at San Francisco; 1992.
2. Holtgrave DR, Pinkerton SD, Jones TS, Lurie P, Vlahov D. Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States. J Acquired Immune Defic Synd Hum Retrovirol 1998; 18(Suppl. 1): S133–S138.
3. Pinkerton SD, Holtgrave DR, Leviton L, Wagstaff D, Abramson PR. Model-based evaluation of HIV prevention interventions. Evaluation Rev 1998; 22: 155–174.
4. Pinkerton SD, Holtgrave DR. A method for evaluating the economic efficiency of HIV behavior risk reduction interventions. AIDS and Behavior, in press.
5. Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-effectiveness in Health and Medicine. New York Oxford University Press; 1996.